prostatic neoplasms
Showing NaN - NaN of 29
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,
Active, not recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Los Angeles, California
- +6 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)
Recruiting
- Prostatic Neoplasms
- Radiotherapy
- +2 more
-
Tucson, Arizona
- +145 more
Jan 17, 2023
Prostatic Tumors Trial in New York, Myrtle Beach, Houston (ORIC-101, enzalutamide 40 MG oral capsule [Xtandi])
Active, not recruiting
- Prostatic Neoplasms
- ORIC-101
- enzalutamide 40 MG oral capsule [Xtandi]
-
New York, New York
- +2 more
Sep 22, 2022
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Prostatic Tumors Trial in United States (Radium-223 dichloride (Xofigo, BAY88-8223), Abiraterone acetate, Prednisone)
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Scottsdale, Arizona
- +18 more
Jul 4, 2019
Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Completed
- Advanced Prostate Cancer
- Prostatic Neoplasms
- sipuleucel-T
-
Bessemer, Alabama
- +332 more
Mar 5, 2019
Prostatic Tumors Trial in Houston (Doxorubicin, Ketoconazole, Docetaxel)
Terminated
- Prostatic Neoplasms
- Doxorubicin
- +4 more
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Nov 2, 2018
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, prednisone)
Completed
- Prostate Cancer
- +3 more
-
Birmingham, Alabama
- +263 more
Feb 14, 2018
Prostatic Tumors Trial in Houston (G-202)
Completed
- Prostatic Neoplasms
-
Houston, TexasUniversity of Texas Health Sciences Center
Feb 22, 2017
Prostatic Tumors Trial in Houston (MVA 5T4, Docetaxel)
Terminated
- Prostatic Neoplasms
- MVA 5T4
- Docetaxel
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Prostatic Tumors Trial in Houston (Abraxane, Leuprolide, Bicalutamide)
Terminated
- Prostatic Neoplasms
- Abraxane
- +2 more
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Prostatic Tumors Trial in Houston (GM-CSF, Ketoconazole, Mitoxantrone)
Terminated
- Prostatic Neoplasms
- GM-CSF
- +2 more
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Prostatic Tumors Trial in Houston (Paclitaxel polyglumex (Xyotax))
Completed
- Prostatic Neoplasms
- Paclitaxel polyglumex (Xyotax)
-
Houston, TexasBaylor College of Medicine -Methodist Hospital
Mar 15, 2016
Prostatic Tumors Trial in Houston (GM-CSF, thalidomide, docetaxel)
Terminated
- Prostatic Neoplasms
- GM-CSF
- +2 more
-
Houston, TexasThe Methodist Hospital Research Institute
Mar 15, 2016
Prostatic Tumors Trial in Houston (TroVax, GM-CSF)
Completed
- Prostatic Neoplasms
- TroVax
- GM-CSF
-
Houston, TexasThe Methodist Hospital Research Institute
Mar 15, 2016
Prostatic Tumors Trial in United States (Radium-223 dichloride (BAY88-8223))
No longer available
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Birmingham, Alabama
- +59 more
Jul 11, 2014
Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)
Completed
- Prostatic Neoplasms
- Placebo
- +2 more
-
Birmingham, Alabama
- +127 more
Apr 10, 2014